• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中糖蛋白140的免疫组化表达与雌激素受体α和孕激素受体A阳性相关。

Immunohistochemical expression of glycodelin in breast cancer correlates with estrogen-receptor alpha and progesterone-receptor A positivity.

作者信息

Scholz Christoph, Toth Bettina, Barthell Elisabeth, Mylonas Ioannis, Weissenbacher Tobias, Friese Klaus, Jeschke Udo

机构信息

Department of Obstetrics and Gynaecology, Ludwig-Maximilians University, Maistrasse 11, Munich, Germany.

出版信息

Histol Histopathol. 2009 Apr;24(4):467-71. doi: 10.14670/HH-24.467.

DOI:10.14670/HH-24.467
PMID:19224449
Abstract

Glycodelin (Gd), previously known as placental protein 14 (PP 14), acts as an immuno-suppressive glycoprotein by suppressing the cytolytic capacity of human natural killer (NK) cells and T-cells in vitro. Glycodelin is expressed in normal glandular epithelium of the endometrium as well as in normal and malignant glandular cells in and outside of the reproductive tract. Recently, Gd expression was demonstrated in normal and cancerous human breast tissue. Paraffin-embedded breast cancer tissue blocks (n=121) were examined for Gd expression. No part of the specimens contained carcinoma in situ. Gd expression was present in lobular and ductal breast carcinoma. We observed expression of Gd in breast cancer independent of grading. With regard to nodal status, no significant differences in the expression of Gd between cancer tissue from patients with or without axillary lymph node metastases were present. However, Gd expression was found to be significantly higher in breast cancer tissue when the staining reaction for steroid receptors was also positive. These results implicate that Gd might be an additional marker for the differentiation of breast cancer tissue. To which extent Gd could serve as an additional indicator for breast cancer survival is part of our ongoing research.

摘要

糖蛋白14(Gd),以前称为胎盘蛋白14(PP 14),在体外通过抑制人类自然杀伤(NK)细胞和T细胞的细胞溶解能力,发挥免疫抑制糖蛋白的作用。糖蛋白14在子宫内膜的正常腺上皮以及生殖道内外的正常和恶性腺细胞中均有表达。最近,在正常和癌性人类乳腺组织中也证实了Gd的表达。对121例石蜡包埋的乳腺癌组织块进行了Gd表达检测。标本中无原位癌部分。小叶癌和导管癌中均存在Gd表达。我们观察到乳腺癌中Gd的表达与分级无关。关于淋巴结状态,有或无腋窝淋巴结转移患者的癌组织中Gd表达无显著差异。然而,当类固醇受体染色反应也呈阳性时,发现乳腺癌组织中Gd表达显著更高。这些结果表明,Gd可能是乳腺癌组织分化的另一个标志物。Gd在多大程度上可作为乳腺癌生存的额外指标,是我们正在进行的研究的一部分。

相似文献

1
Immunohistochemical expression of glycodelin in breast cancer correlates with estrogen-receptor alpha and progesterone-receptor A positivity.乳腺癌中糖蛋白140的免疫组化表达与雌激素受体α和孕激素受体A阳性相关。
Histol Histopathol. 2009 Apr;24(4):467-71. doi: 10.14670/HH-24.467.
2
Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.人乳腺癌中糖蛋白15的表达:原位癌、浸润性癌及其淋巴结转移灶的免疫组化分析
Anticancer Res. 2005 May-Jun;25(3A):1761-4.
3
Glycodelin expression in correlation to grading, nodal involvement and steroid receptor expression in human breast cancer patients.糖蛋白 130 在人乳腺癌患者中的表达与分级、淋巴结转移及甾体激素受体表达的相关性研究。
Anticancer Res. 2010 May;30(5):1599-603.
4
Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence.人乳腺导管原位癌、浸润性导管癌、其淋巴结及远处转移灶以及复发性导管癌中糖蛋白和信使核糖核酸的表达
Oncol Rep. 2005 Mar;13(3):413-9.
5
Expression of glycodelin in human breast and breast cancer.
Int J Cancer. 1999 Dec 10;83(6):738-42. doi: 10.1002/(sici)1097-0215(19991210)83:6<738::aid-ijc7>3.0.co;2-f.
6
Glycodelin in ovarian serous carcinoma: association with differentiation and survival.卵巢浆液性癌中的糖蛋白15:与分化和生存的关系
Cancer Res. 2003 Oct 1;63(19):6258-64.
7
Immunohistochemical study of KiSS1 and KiSS1R expression in human primary breast cancer: Association with breast cancer receptor status, proliferation markers and clinicopathological features.人原发性乳腺癌中KiSS1和KiSS1R表达的免疫组织化学研究:与乳腺癌受体状态、增殖标志物及临床病理特征的关联
Histol Histopathol. 2015 Jun;30(6):715-23. doi: 10.14670/HH-30.715. Epub 2014 Dec 23.
8
Pregnancy-associated plasma protein-A expression in human breast cancer.妊娠相关血浆蛋白-A在人类乳腺癌中的表达
Growth Horm IGF Res. 2014 Dec;24(6):264-7. doi: 10.1016/j.ghir.2014.10.007.
9
Immunolocalization of glycodelin in human adenocarcinoma of the lung, squamous cell carcinoma of the lung and lung metastases of colonic adenocarcinoma.糖蛋白 130 在人肺腺癌、肺鳞癌和结肠腺癌肺转移中的免疫组化定位。
Acta Histochem. 2011 Dec;113(8):798-802. doi: 10.1016/j.acthis.2010.11.009. Epub 2010 Dec 18.
10
COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.COX-2 在人乳腺癌中的表达:与临床病理特征和预后分子标志物的相关性。
Expert Opin Ther Targets. 2010 Jul;14(7):655-64. doi: 10.1517/14728222.2010.486792.

引用本文的文献

1
Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical Cancer.孕激素受体 A 的表达作为宫颈癌独立的负预后预测因子。
Int J Mol Sci. 2023 Feb 1;24(3):2815. doi: 10.3390/ijms24032815.
2
Prognostic Relevance of Nuclear Receptors in Relation to Peritumoral Inflammation and Tumor Infiltration by Lymphocytes in Breast Cancer.核受体与乳腺癌肿瘤周围炎症及淋巴细胞肿瘤浸润的预后相关性
Cancers (Basel). 2022 Sep 20;14(19):4561. doi: 10.3390/cancers14194561.
3
Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer.
gatipotuzumab 表位 TA-MUC1 与卵巢癌雌激素受体的潜在相互作用。
Int J Mol Sci. 2019 Jan 12;20(2):295. doi: 10.3390/ijms20020295.
4
TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer.由完全人源化的治疗性抗体 Gatipotzumab 检测到的 TA-MUC1 预测宫颈癌预后不良。
J Cancer Res Clin Oncol. 2018 Oct;144(10):1899-1907. doi: 10.1007/s00432-018-2706-5. Epub 2018 Jul 30.
5
The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.G蛋白偶联雌激素受体(GPER/GPR30)可能作为早期宫颈癌的一种预后标志物。
J Cancer Res Clin Oncol. 2018 Jan;144(1):13-19. doi: 10.1007/s00432-017-2510-7. Epub 2017 Sep 18.
6
Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.全人源治疗性抗体PankoMab-GEX™的免疫反应性是乳腺癌患者的独立预后标志物。
J Exp Clin Cancer Res. 2015 May 19;34(1):50. doi: 10.1186/s13046-015-0152-7.